Overview on Flualprazolam
Flualprazolam is a potent, unmarketed triazolobenzodiazepine designer drug structurally similar to alprazolam (Xanax).
Overview and Identification
- Class: Triazolobenzodiazepine (a subclass of benzodiazepines). [1]
- History: Synthesized in 1976 but never approved or marketed for medical use. [1]
- Appearance: Often sold illicitly online as a “research chemical” or pressed into counterfeit pills mimicking prescription drugs like Xanax or Klonopin. [1, 2]
- Chemical difference: Differs from alprazolam by the addition of a single fluorine atom, making it significantly stronger and longer-lasting. [1, 2, 3]
Effects and Pharmacology
- Mechanism: Acts as a central nervous system (CNS) depressant by binding to GABA receptors. [1, 2]
- Timeline: Onset occurs within 10 to 30 minutes, peak effects happen after several hours, and total duration lasts 6 to 14 hours. [1]
- Common effects: Sedation, heavy relaxation, drowsiness, dizziness, and motor impairment. [1, 2, 3]
- Risks: High potential for abuse, physical dependence, and severe overdose—especially when mixed with other depressants like alcohol or opioids. [1, 2]
Legal Status
- International: Recommended for international control by the World Health Organization (WHO).
- United States: Classified as a Schedule I controlled substance with no accepted medical use.
- Global: Banned or heavily restricted in multiple countries, including Sweden, the UK, Germany, Canada, and Brazil. [1, 2, 3]
If you want, tell me:
- Are you looking for information on drug testing and detection timelines?
- Do you need resources or guidance related to substance use support or withdrawal safety?
Reviews
There are no reviews yet.